| Financial Year |
March 31 2023 |
| Monetary Funds |
1,020,296,575.04 |
| Held-for-trading Financial Assets |
6,000,000.00 |
| Notes Receivable |
138,239,787.37 |
| Accounts Receivable |
1,304,350,423.63 |
| Advances to Suppliers |
527,155,309.17 |
| Other Receivables |
80,339,764.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
823,805,869.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
64,062,084.08 |
| Total Current Assets |
4,287,688,578.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
69,888,920.54 |
| Investment Properties |
32,812,713.30 |
| Fixed Assetes |
1,091,243,117.84 |
| Under-construction Projects |
47,266,640.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,405,711.34 |
| R&D expenses |
-- |
| Goodwill |
408,696,807.00 |
| Long-Term Deferred and Prepaid Expenses |
1,721,272.23 |
| Deferred Income Tax Assets |
141,895,023.61 |
| Other Non-Current Assets |
163,870,545.93 |
| Sub-Total of Non-Current Assets |
2,193,921,514.62 |
| Total Assets |
6,481,610,092.75 |
| Short-Term Loans |
594,615,989.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
417,611,768.03 |
| Accounts Payable |
908,082,040.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,740,455.56 |
| Taxes Payable |
2,570,501.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,830,032.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,723,801.41 |
| Other Current Liabilities |
149,332,614.44 |
| Sub-Total of Current Liabilities |
2,959,081,188.40 |
| Long-term Loans |
344,763,596.03 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,408,726.37 |
| Deferred Income Tax Liabilities |
25,399,481.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
498,540,851.29 |
| Total Liabilities |
3,457,622,039.69 |
| Paid-In Capital(Or Share Stock) |
394,193,274.00 |
| Capital Surplus |
2,592,067,741.85 |
| Surplus Reserve |
36,961,723.01 |
| LESS:Treasury Stock |
2,553,600.00 |
| Undistributed Profits |
-71,619,628.08 |
| Minority Stockholder's Interest |
76,585,536.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,947,402,516.94 |
| Owner's Equity（Stockholder's Equity） |
3,023,988,053.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,481,610,092.75 |
